Radionuclide imaging for the cell apoptosis is a direct, noninvasive, and real-time imaging technique. It is a hopeful method for observing brain and myocardial ischemic reperfusion injury, detecting allograft rejection, and evaluating the effects of tumor chemotherapy and radiotherapy. This paper introduces the design, mechanisms, and applications of radionuclide agents based on preclinical studies.